Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria.
Rodicio
J L
JL
Department of Nephrology, 12 Octubre Hospital, Madrid, Spain.
Alcazar
J M
JM
Ruilope
L M
LM
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002216:Captopril / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use; D011507:Proteinuria / Q000188:drug therapy*; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D006830:Hydralazine; D005665:Furosemide; D002216:Captopril; D011433:Propranolol